IDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantation.

Adrien CailletMarion Simonet-BoissardEdouard ForcadeMarie RobinMarie-Thérèse RubioMarie-Anne CouturierMicha SrourNatacha MaillardRaynier DevillierAnne HuynhJean-Henri BourhisCélestine SimandSylvain ChantepieCyril BoissonMarie KroemerErick DeconinckAna Berceanu

Published in: HemaSphere (2024)

Keyphrases

acute myeloid leukemia
stem cell transplantation
acute lymphoblastic leukemia
bone marrow
diffuse large b cell lymphoma
low grade
hodgkin lymphoma
low dose
hematopoietic stem cell
high grade